Uses and complications of isotretinoin therapy

Journal of the American Academy of Dermatology

Volumn 45, Issue 5, 2001, Pages S150-S157

  Ellis, Charles N ^a   Krach, Kent J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; CONFERENCE PAPER; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PSORIASIS; SKIN CANCER; SKIN DISEASE; TERATOGENICITY;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADULT; AGED; AGING; DERMATOLOGIC AGENTS; HUMANS; ISOTRETINOIN; MIDDLE AGED; PSORIASIS; SKIN DISEASES; SKIN NEOPLASMS;

EID: 0034754252     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.113717     Document Type: Article

References (113)

1. The uses of retinoids in dermatology
2. Topical retinoids
3. Factors associated with the therapeutic efficacy of retinoic acids on malignant lymphoma
4. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer
5. In vitro effects of retinoids on human lymphocyte functions
6. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid
7. The role of isotretinoin in the treatment of acne: Personal observations
8. Recurrence rates after the first course of isotretinoin
9. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea
10. Acne vulgaris in the elderly: The response to low-dose isotretinoin
11. Management of adult acne and acne variants
12. Solid persistent facial oedema (Morbihan's disease) following rosacea, successfully treated with isotretinoin and ketotifen
13. Acneiform dermatoses
14. Disseminated and recurrent infundibular folliculitis (DRIF): Report of a case successfully treated with isotretinoin
15. Chloracne in the 1990s
16. Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa
17. Treatment of lamellar ichthyosis and other keratinising dermatoses with an oral synthetic retinoid
18. The retinoids
19. Systemic retinoid medication and periodontal health in patients with Papillon-Lefevre syndrome
20. Retinoid hyperostoses: Skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for refractory ichthyosis
21. Pityriasis rubra pilaris: Further observations of systemic retinoid therapy
22. Adult pityriasis rubra pilaris: A 10-year case series
23. Cyclosporine consensus conference: With emphasis on the treatment of psoriasis
24. Systemic sequential therapy of psoriasis: A new paradigm for improved therapeutic results
25. Etretinate: A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders
26. Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment
27. A case of atrophoderma vermiculatum responding to isotretinoin
28. Isotretinoin for refractory lupus
29. Retinoids in lichen planus
30. Cutaneous sarcoidosis: Complete remission after oral isotretinoin therapy
31. Treatment of cutaneous sarcoidosis with isotretinoin
32. Resolution of generalized granuloma annulare with isotretinoin therapy
33. Retinoids in the management of non-melanoma skin cancer and melanoma
34. Two patients with confluent and reticulated papillomatosis: Response to oral isotretinoin and 10% lactic acid lotion
35. Axillary granular parakeratosis: Response to isotretinoin
36. Premature familial sebaceous hyperplasia: Successful response to oral isotretinoin in three patients
37. Isotretinoin for the treatment of sebaceous hyperplasia
38. Isotretinoin for sebaceous skin lesions in Muir-Torte syndrome: A case report
39. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: Long-term follow-up
40. Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment or recurrent condylomata accuminata
41. Langerhans' cell histiocytosis: Complete remission after oral isotretinoin therapy
42. Follicular mucinosis successfully treated with isotretinoin
43. Isotretinoin in cutaneous T-cell lymphoma
44. Papular mucinosis associated with AIDS: Response to isotretinoin
45. Isotretinoin treatment of human immunodeficiency virus-associated eosinophilic folliculitis
46. Comparative effects of retinoic acid, glycolic acid and a lipophilic derivative of salicylic acid of photodamaged epidermis
47. Retinoids and photodamage
48. Topical tretinoin improves photoaged skin: A double-blind vehicle-controlled study
49. Sustained improvement with prolonged tretinoin (retinoic acid) for photoaged skin
50. Topical tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: A vehicle-controlled trial
51. Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage
52. Topical tretinoin (retinoic acid) improves melasma: A vehicle-controlled, clinical trial
53. Topical retinoic acid (tretinoin) for melasma in black patients: A vehicle-controlled clinical trial
54. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients
55. Retinoic acid inhibits induction of c-jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo
56. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment
57. Restoration of collagen formation in photodamaged skin by tretinoin
58. Topical tretinoin (retinoic acid) improves early stretch marks
59. Managing actinic keratoses with retinoids
60. Retinoid chemoprevention in the high-risk patient
61. Trial of retinol and isotretinoin in skin cancer prevention: A randomized, double-blind, controlled trial
62. Low dose isotretinoin in the prophylaxis of skin cancer in renal transplant patients
63. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome
64. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin
65. Chemoprevention of skin cancer in xeroderma pigmentosum
66. Multiple keratoacanthomas and keratoacanthoma centrifugum marginatum: Development in a single patient and treatment with oral isotretinoin
67. Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention
68. Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma
69. Phase II clinical trial of recombinant alfa 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma
70. Interferon alfa-2a and 13-cis-retinoic acid in renal cell carcinoma: Antitumor activity in a phase II trial and interactions in vitro
71. Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma
72. Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen
73. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha: A phase II study
74. 13-cis-retinoic acid and interferon-alpha 2a therapy in locally advanced squamous cell carcinoma of the cervix: p53 alteration, proliferating cell nuclear antigen expression and angiogenesis response
75. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial
76. A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix
77. Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma
78. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid
79. Resolution of recurrent malignant ganglioglioma after treatment with cis-retinoic acid
80. Xeroderma pigmentosum: Spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy
81. Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basics and first clinical results
82. Isotretinoin in metastatic thyroid cancer
83. A pilot trial of 13-cis-retinoic acid and alpha-tocopherol with recombinant human erythropoietin in myelodysplasic syndrome patients with progressive or transfusion-dependent anemias
84. Remission after 13-cis retinoic acid in thrombotic thrombocytopenic purpura
85. Etretinate therapy
86. A pregnancy-prevention program in women of childbearing age receiving isotretinoin
87. Hypervitaminosis A syndrome: A paradigm of retinoid side effects
88. The vitamin A content and toxicity of polar bear and seal liver
89. Monitoring of isotretinoin therapy by measuring the plasma levels of isotretinoin and 4-oxo-isotretinoin
90. The role of isotretinoin in the treatment of acne: Personal observations
91. The uses of retinoids in dermatology
92. Retinoid therapy is associated with excess granulation tissue responses
93. Acne fulminans
94. Long-term safety of isotretinoin as a treatment for acne vulgaris
95. Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol
96. Clinical pearl: Vitamin E (alpha-tocopherol), 800 IU daily, may reduce retinoid toxicity
97. Ocular side-effects of Accutane therapy
98. Abnormal retinal function associated with isotretinoin therapy for acne
99. Rod and cone malfunction as a manifestation of isotretinoin therapy a case report
100. Retinal toxicity of systemic drugs
101. Retinoic acid embryopathy
102. Safety of pregnancy after discontinuation of isotretinoin
103. Roaccutane treatment guidelines: Results of an international survey
104. Acitretin (RO10-1670) and oral contraceptives: Interaction study
105. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin)
106. Retinoid hepatitis
107. Isotretinoin-associated normalization of hyperbilirubinemia in patients with Gilbert's syndrome
108. Systemic 13-cis retinoic acid therapy and exacerbation of colitis
109. Adverse effects of isotretinoin therapy
110. Oral isotretinoin and inflammatory bowel disease
111. Treatment of severe acne with isotretinoin in patients with inflammatory bowel disease